Global Food Allergy Diagnosis & Treatment Market is estimated to be valued at USD 18,083.2 million by 2023 and expected to grow at a CAGR of 3.14% during the forecast period. Among food source, the seafood segment accounted for the largest market share. However, milk food source segment has been projected to grow at the highest CAGR on account of increasing cases of lactose intolerance in Europe and North America.
In the diagnosis segment, secondary diagnosis steps such as Polymerase Chain Reaction (PCR), Enzyme-linked IMMUNOSORBENT Assay (ELISA), and others are expected to garner larger market share in comparison to primary diagnosis steps which includes skin prick test, blood test, food elimination diet test, and others. The major factor responsible for the market growth is the growing awareness regarding food-borne allergies and their expensive screening costs.
Get Free Sample Copy of “Food Allergy Diagnosis and Treatment Market” @ https://www.marketresearchfuture.com/sample_request/7562
The prominent players in the Global Food Allergy Diagnosis & Treatment Market are SGS S.A. (Switzerland), Intertek Group PLC (UK), TÜV SÜD AG (Singapore), ALS Limited (Australia), Eurofins Scientific SE (Luxembourg), Mérieux NutriSciences Corporation (US), AsureQuality Limited (New Zealand), and Microbac Laboratories Inc. (US).
Global Food Allergy Diagnosis & Treatment Market has been segmented on the basis of food source, diagnosis, treatment, end-use, and region. On the basis of food source, the market has been divided into eggs, milk, peanuts, seafood, tree nuts, wheat, soy, and others. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Milk allergy is most common in infants and children; however, it can develop at any age. Peanuts are the most common cause of food allergy. Tree nuts include almonds, walnuts, hazelnuts, pine nuts, pecans, and lychee nuts, among others. Wheat allergy is an allergic reaction caused by the consumption of wheat and food containing wheat. Soy allergy mainly starts in infancy with reaction to soy-based infant formula. Milk segment is projected to grow at the highest CAGR of 3.87% during the forecast period.
Based on diagnosis, the global food allergy diagnosis & treatment market is segmented into primary and secondary. The primary segment includes—skin prick test, blood test, food elimination diet test, and others. This segment is expected to grow at a CAGR of 3.40% over the forecast period.
On the basis of treatment, the Global Food Allergy Diagnosis and Treatment Market is segmented into antihistamines and adrenalin & corticosteroids. Antihistamines & corticoids segment is projected to grow at the highest CAGR of 3.42% over the forecast period while adrenalin segment is expected to grow at a CAGR of 3.39% over the forecast period.
Geographically, the global food allergy diagnosis & treatment market is segmented into Asia-Pacific, Europe, Americas, and the Middle East & Africa. As per MRFR analysis, Americas dominated the market, accounted for the largest share of the market in 2018, and expected to grow at a CAGR of 2.93%. Americas market is followed by Europe, which is accounting for the second largest number of shares in the global food allergy diagnosis & treatment market, as of 2018.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562
Key Findings of the Study
The global food allergy diagnosis and treatment market is expected to reach USD 18,083.2 million by 2023 from US D 14,849.5 million in 2017 and is expected to register a CAGR of 3.41% during the forecast period from 2018 to 2023.
In 2017, the market was led by the Americas with a 50.79% share, followed by Europe and Asia-Pacific
On the basis of food source, the seafood segment accounted for the largest market share of 21.86% in 2017. The milk segment is expected to account for the highest CAGR of 3.87% during the forecast period.
NOTE: Our Team of Researchers is Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.